SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-119762
Filing Date
2024-04-29
Accepted
2024-04-29 07:12:31
Documents
16
Period of Report
2024-04-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d831713d8k.htm   iXBRL 8-K 48110
2 EX-2.1 d831713dex21.htm EX-2.1 590368
3 EX-99.1 d831713dex991.htm EX-99.1 20058
7 GRAPHIC g831713g0429103212640.jpg GRAPHIC 3142
  Complete submission text file 0001193125-24-119762.txt   940509

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dcph-20240429.xsd EX-101.SCH 2856
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dcph-20240429_lab.xml EX-101.LAB 17235
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dcph-20240429_pre.xml EX-101.PRE 10816
19 EXTRACTED XBRL INSTANCE DOCUMENT d831713d8k_htm.xml XML 3494
Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38219 | Film No.: 24886571
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)